| http://www.w3.org/ns/prov#value | - Restructuring costs mainly comprised expenses incurred by the Group to accelerate the implementation of transformation such as adaptation of support functions, reorganisation of Research and Development activities and the cost associated with the transfer of the activities of US affiliate Ipsen Bioscience from the Milford site to the Cambridge site, following the sale of the Milford site to Baxter
|
